Adial Pharmaceuticals share price logo

Adial Pharmaceuticals

NASDAQ: ADIL

$5.05

+1.34

(+36.12%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 28 Oct 2026

Adial Pharmaceuticals Stock Performance

as on October 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.80
    $5.15
    downward going graph

    24.75%

    Downside

    1.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.31
    $9.30
    downward going graph

    74.06%

    Downside

    84.16%

    Upside

    downward going graph

Adial Pharmaceuticals share price movements today

Previous Close
$3.71
Open
$3.99
Volume
198.5K
Market Cap
$9.7M
Day's Low - High
$3.80 - $5.15
52 Week Low - High
$1.31 - $9.30

Adial Pharmaceuticals Historical Returns

1 Month Return
+ 21.69 %
3 Month Return
+ 60.32 %
1 Year Return
-42.32 %
3 Year Return
-90.05 %
5 Year Return
-99.75 %

Adial Pharmaceuticals Stock Fundamentals & Key Indicators

Check Adial Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.7M

EPS (TTM)

-16.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.22

Industry PE ratio

-2.82

PEG Ratio

0.01

EBITDA

-57.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-1693.21%

Adial Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adial Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$9.7M-99.75%-0.220.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Adial Pharmaceuticals Stock including INR - Dollar returns

The Adial Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Adial Pharmaceuticals investment value today

Current value as on today

₹61,793

Returns

-₹38,207

(-38.21%)

Returns from Adial Pharmaceuticals Stock

-₹42,319 (-42.32%)

Dollar Impact

₹4,112 (+4.11%)

Analyst Recommendation on Adial Pharmaceuticals Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Adial Pharmaceuticals. Average target price of $8.33

Adial Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Adial Pharmaceuticals.

What analysts predicted

39.38%UPSIDE

Target Price

$8.33

Current Price

$5.05

Analyzed by

9 Analysts

Target

$8.33

Adial Pharmaceuticals target price $8.33, a slight upside of 39.38% compared to current price of $5.05. According to 9 analysts rating.

Indian Investors' Interest in Adial Pharmaceuticals Stock

Search interest for Adial Pharmaceuticals Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Adial Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
-
0
-
-
-
-
0
-
Operating Income
-1
-2
-2
-1
-2
-1
-1
-1
-2
-52
EBITDA
-6
-2
-2
-2
-2
-1
-1
-1
-2
-51
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-6
-2
-2
-2
-2
-1
-1
-1
-2
-51
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-6
-2
-2
-2
-2
-1
-1
-1
-2
-51
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Adial Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
0
-
-
Operating Income
0
-6
-8
-10
-19
-10
-6
-8
-7
EBITDA
0
-6
-8
-10
-17
-10
-7
-13
-7
Interest Expense
0
1
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-11
-8
-10
-19
-10
-7
-13
-7
Income Tax Expense
0
-
-
0
0
-
-
-
-
Net Income
-1
-11
-8
-10
-19
-12
-7
-13
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Adial Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-2
-2
-2
-2
-
-1
-1
-2
-51
Operating Cash Flow
-1
-2
-1
-1
-1
-1
-1
-1
-1
-6
Investing Cash Flow
-
-
-
-
0
-
-
-
-
5
Financing Cash Flow
3
0
3
-
0
5
0
2
0
25
Change in Cash
2
-1
1
-1
-1
3
-1
1
-1
24

Adial Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-1
-11
-8
-10
-19
-12
-7
-13
-7
Operating Cash Flow
0
-2
-6
-7
-11
-11
-6
-6
-6
Investing Cash Flow
0
-
-
0
0
-
1
-
0
Financing Cash Flow
0
6
9
5
13
9
4
7
8
Change in Cash
0
3
2
-2
1
-2
-1
0
2

Global Institutional Holdings in Adial Pharmaceuticals

Check out the Institutions with significant holdings in Adial Pharmaceuticals.

Funds
Holdings
Vanguard
0.40%
Fidelity Concord Street Trust
0.23%
VANGUARD INDEX FUNDS
0.01%

Adial Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 16 October

    Fri, 04:41 PM

    -

    Adial Pharmaceuticals appoints David Rubenstein as chief scientist to lead research and development strategy.

    Sat, 03:21 AM

    -

    Adial Pharmaceuticals adjourns stockholder meeting pending Nasdaq listing approval, with a Buy rating and $11.00 price target.

Insights on Adial Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ADIL stock has moved up by 225.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 767.1% return, outperforming this stock by 809.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 197.8% return, outperforming this stock by 287.8%

About Adial Pharmaceuticals

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
OrganisationAdial Pharmaceuticals
Headquarters4870 Sadler Road, Glen Allen, VA, 23060, US
IndustryBiotechnology
CEOCary John Claiborne

Key Management of Adial Pharmaceuticals

Name

Title

Mr. Cary John Claiborne MBA

CEO, President & Director

Mr. Vinay Shah A.C.A., C.P.A., M.B.A.

CFO & Treasurer

FAQs

What is Adial Pharmaceuticals share price today?

Adial Pharmaceuticals share price today is $5.05 as on at the close of the market. Adial Pharmaceuticals share today touched a day high of $5.15 and a low of $3.80.

What is the 52 week high and 52 week low for Adial Pharmaceuticals share?

Adial Pharmaceuticals share touched a 52 week high of $9.30 on and a 52 week low of $1.31 on . Adial Pharmaceuticals stock price today i.e. is closed at $5.05,which is 45.70% down from its 52 week high and 285.50% up from its 52 week low.

What is Adial Pharmaceuticals's market capitalisation today?

Adial Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Adial Pharmaceuticals Stock (ADIL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adial Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Adial Pharmaceuticals Stock (ADIL) from India?

Indian investors can start investing in Adial Pharmaceuticals (ADIL) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Adial Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Adial Pharmaceuticals share’s latest price of $5.05 as on October 29, 2026 at 8:46 am IST, you will get 1.9802 shares of Adial Pharmaceuticals. Learn more about fractional shares .

What are the returns that Adial Pharmaceuticals has given to Indian investors in the last 5 years?

Adial Pharmaceuticals stock has given -99.75% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?